Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Sep 29, 2020
|
staff reporter

NEW YORK —  Oxford Immunotec said on Tuesday that it has received clearance from the US Food and Drug Administration to amend the pediatric age limitation for its T-Spot.TB tuberculosis (TB) test to include individuals two years of age and older.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Infectious Disease

  1. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  2. Chembio Nabs CE Mark for SARS-CoV-2 Tests, Inks Distribution Agreement with Luas Diagnostics

  3. Ortho Clinical Diagnostics COVID-19 Antigen Test Receives FDA EUA for High-Volume Testing

  4. Oxford Immunotec, Valneva Collaborate on COVID-19 Vaccine Study

  5. BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.